BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25884318)

  • 1. Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
    Pakpoor J; Seminog OO; Ramagopalan SV; Goldacre MJ
    BMC Neurol; 2015 Feb; 15():16. PubMed ID: 25884318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies.
    Fois AF; Wotton CJ; Yeates D; Turner MR; Goldacre MJ
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):215-21. PubMed ID: 19726405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential risks of cancer types in people with Parkinson's disease: a national record-linkage study.
    Ong EL; Goldacre R; Goldacre M
    Eur J Cancer; 2014 Sep; 50(14):2456-62. PubMed ID: 25065294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gout and the risk of Parkinson's disease: a cohort study.
    De Vera M; Rahman MM; Rankin J; Kopec J; Gao X; Choi H
    Arthritis Rheum; 2008 Nov; 59(11):1549-54. PubMed ID: 18975349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birthplace as a risk factor in motor neurone disease and Parkinson's disease.
    Betemps EJ; Buncher CR
    Int J Epidemiol; 1993 Oct; 22(5):898-904. PubMed ID: 8282470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farming and incidence of motor neuron disease: French nationwide study.
    Kab S; Moisan F; Elbaz A
    Eur J Neurol; 2017 Sep; 24(9):1191-1195. PubMed ID: 28727213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between gout and the development of Parkinson's disease: a systematic review and meta-analysis.
    Fazlollahi A; Zahmatyar M; Alizadeh H; Noori M; Jafari N; Nejadghaderi SA; Sullman MJM; Gharagozli K; Kolahi AA; Safiri S
    BMC Neurol; 2022 Oct; 22(1):383. PubMed ID: 36221048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gout, hyperuricemia, and Parkinson's disease: a protective effect?
    Alonso A; Sovell KA
    Curr Rheumatol Rep; 2010 Apr; 12(2):149-55. PubMed ID: 20425025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Parkinson's disease following gout: a population-based retrospective cohort study in Taiwan.
    Hu LY; Yang AC; Lee SC; You ZH; Tsai SJ; Hu CK; Shen CC
    BMC Neurol; 2020 Sep; 20(1):338. PubMed ID: 32900384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of motor neuron diseases in gout patients: a nationwide population-based cohort study.
    Kwon HS; Park Y; Kim JH; Kim SH; Jun JB; Park S; Kang DR; Choi H
    Neurol Sci; 2023 Feb; 44(2):593-600. PubMed ID: 36271260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Parkinson's disease in a gout Mediterranean population: A case-control study.
    Pou MA; Orfila F; Pagonabarraga J; Ferrer-Moret S; Corominas H; Diaz-Torne C
    Joint Bone Spine; 2022 Nov; 89(6):105402. PubMed ID: 35504516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of fractures in patients with multiple sclerosis: record-linkage study.
    Ramagopalan SV; Seminog O; Goldacre R; Goldacre MJ
    BMC Neurol; 2012 Nov; 12():135. PubMed ID: 23126555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies.
    Seminog OO; Goldacre MJ
    Rheumatology (Oxford); 2013 Dec; 52(12):2251-9. PubMed ID: 24046469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urate and the risk of Parkinson's disease in men and women.
    Cortese M; Riise T; Engeland A; Ascherio A; Bjørnevik K
    Parkinsonism Relat Disord; 2018 Jul; 52():76-82. PubMed ID: 29615298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis and risk of Parkinson's disease: a Danish nationwide cohort study.
    Nielsen NM; Pasternak B; Stenager E; Koch-Henriksen N; Frisch M
    Eur J Neurol; 2014; 21(1):107-11. PubMed ID: 24053187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.
    Goldacre MJ; Duncan M; Griffith M; Turner MR
    J Neurol; 2010 May; 257(5):706-15. PubMed ID: 19946783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gout is not associated with a lower risk of Parkinson's disease: A systematic review and meta-analysis.
    Ungprasert P; Srivali N; Thongprayoon C
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1238-42. PubMed ID: 26330027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel biomarker for neurodegenerative diseases- motor neuron disease (MND), cerebellar ataxia (CA) and Parkinson's disease (PD).
    Pandey S; Singh B; Yadav SK; Mahdi AA
    Clin Chim Acta; 2018 Oct; 485():258-261. PubMed ID: 30006282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gout and risk of Parkinson disease: a prospective study.
    Alonso A; Rodríguez LA; Logroscino G; Hernán MA
    Neurology; 2007 Oct; 69(17):1696-700. PubMed ID: 17954784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gout and the risk of Parkinson's disease in older adults: a study of U.S. Medicare data.
    Singh JA; Cleveland JD
    BMC Neurol; 2019 Jan; 19(1):4. PubMed ID: 30611222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.